Correction: Share subscriptions based on Nanoform Finland Plc’s stock options 1/2020 and 2/2019
Company release Nanoform Finland Plc December 18, 2023 16.00 Finnish…
Share subscriptions based on Nanoform Finland Plc’s stock options 1/2019 and 2/2019
Company release Nanoform Finland Plc December 5, 2023 18.00 Finnish…
Nanoform Finland Plc – Manager’s transactions – Miguel Calado
Company release Nanoform Finland Plc November 29, 2023 09.00 Finnish…
Nanoform Finland Plc – Manager’s transactions – Albert Hæggström
Company release Nanoform Finland Plc November 29, 2023 09.00 Finnish…
Nanoform Finland Plc – Manager’s transactions – Mads Laustsen
Company release Nanoform Finland Plc November 29, 2023 09.00 Finnish…
Nanoform Finland Plc – Manager’s transactions – Jeanne Thoma
Company release Nanoform Finland Plc November 29, 2023 09.00 Finnish…
Nanoform Q3 2023: Nanoformed blockbuster drug enters clinic and another nanoformed drug received FDA orphan designation
Company Announcement Nanoform Finland Plc November 22, 2023 08:10 a.m.…
Invitation to Nanoform’s Q3 2023 Interim Report
Press release Nanoform Finland Plc November 8, 2023 11:00 a.m.…
Nanoform grant Global STARMAP[®] AI License to AstraZeneca
Press release Nanoform Finland Plc October 23, 2023 08:10 Finnish…
Nanoformed TargTex oncology drug candidate TTX101 receives FDA Orphan Drug Designation
Press release Nanoform Finland Plc October 19, 2023 12:15 Finnish…
Nanoform Finland Plc – Managers’ transactions – Albert Hæggström
Company release Nanoform Finland Plc September 13, 2023 17:30 Finnish…
Nanoform Finland Plc – Managers’ transactions – Antonio Da Silva
Company release Nanoform Finland Plc September 13, 2023 17:30 Finnish…
Nanoform Finland Plc – Managers’ transactions – Christian Jones
Company release Nanoform Finland Plc September 13, 2023 17:30 Finnish…
Nanoform Finland Plc – Managers’ transactions – Peter Hänninen
Company release Nanoform Finland Plc September 13, 2023 17:30 Finnish…
Nanoform Finland Plc – Managers’ transactions – David Rowe
Company release Nanoform Finland Plc September 13, 2023 17:30 Finnish…
Nanoform Finland Plc – Managers’ transactions – Johanna Kause
Company release Nanoform Finland Plc September 13, 2023 17:30 Finnish…
The Board of Directors of Nanoform Finland Plc decided on issue of stock options to key employees
Company release Nanoform Finland Plc September 12, 2023 4:30 p.m.…
Nanoform Finland Plc – Manager’s transactions – Miguel Calado
Company release Nanoform Finland Plc August 29, 2023 18:10 Finnish…
Nanoform Finland Plc – Manager’s transactions – Albert Hæggström
Company release Nanoform Finland Plc August 29, 2023 18:10 Finnish…
Nanoform Finland Plc – Manager’s transactions – Mads Laustsen
Company release Nanoform Finland Plc August 29, 2023 18:10 Finnish…
Nanoform Finland Plc – Manager’s transactions – Jeanne Thoma
Company release Nanoform Finland Plc August 29, 2023 18:10 Finnish…
Nanoform Q2 2023 – A record 11 new customer projects signed and targeting first license/commercial supply agreement in 2024
Company Announcement Nanoform Finland Plc August 24, 2023 08:10 a.m.…
Invitation to Nanoform’s Q2 2023 Interim Report
Press release Nanoform Finland Plc August 10, 2023 11:00 a.m.…
Nanoform and Celanese Demonstrate Enhanced Drug Delivery through the Power of Smaller Implants
Press release Nanoform Finland Plc June 15, 2023 08:10 a.m.…
Nanoform Finland Plc – Manager’s transactions – Miguel Calado
Company release Nanoform Finland Plc May 31, 2023 09:30 Finnish…
Nanoform Finland Plc – Manager’s transactions – Albert Hæggström
Company release Nanoform Finland Plc May 31, 2023 09:30 Finnish…
Nanoform Finland Plc – Manager’s transactions – Jeanne Thoma
Company release Nanoform Finland Plc May 31, 2023 09:30 Finnish…
Nanoform Finland Plc – Manager’s transactions – Mads Laustsen
Company release Nanoform Finland Plc May 31, 2023 09:30 Finnish…
Nanoform Q1 2023 interim report – A strong start to the new year
Company Announcement Nanoform Finland Plc May 25, 2023 08:10 a.m.…
Invitation to Nanoform’s Q1 2023 Interim Report
Press release Nanoform Finland Plc May 11th, 2023 11:00 a.m.…
FIMEA renews Nanoform’s GMP license and Nanoform starts clinical API manufacturing of a blockbuster medicine candidate
Press release Nanoform Finland Plc May 9, 2023 15.00 Finnish…
Share subscriptions based on Nanoform Finland Plc’s stock options 3-5/2019 and 1/2020
Company release Nanoform Finland Plc April 12, 2023 15:01 Finnish…
Resolutions of the Constitutive Meeting of the Board of Directors of Nanoform Finland Plc
Company release Nanoform Finland Plc April 12, 2023 15.00 Finnish…
Resolutions of Nanoform Finland Plc’s Annual General Meeting on April 12, 2023
Company release Nanoform Finland Plc April 12, 2023 14:00 Finnish…
Notice to the Annual General Meeting of NANOFORM FINLAND Plc
Company Announcement Nanoform Finland Plc March 15, 2023 15:00 Finnish…
Kutsu Nanoform Finland Oyj:n varsinaiseen yhtiökokoukseen
Yhtiötiedote Nanoform Finland Oyj 15 Maaliskuuta, 2023 15:00 Suomen aikaa…
Nanoform reports continued progress in 2022 and sets new targets for 2023
Company Announcement Nanoform Finland Plc February 28, 2023 08:10 a.m.…
Invitation to Nanoform Q4 and FY2022 report
Press release Nanoform Finland Plc February 14th, 2023 11:00 a.m.…
Share subscriptions based on Nanoform Finland Plc’s stock options 3-5/2019 and 1/2020
Company release Nanoform Finland Plc January 11, 2023 09:00 a.m.…
Nanoform Finland Plc – Manager’s transactions – Antonio da Silva
Company release Nanoform Finland Plc January 11, 2023 09:00 a.m.…